Enhancement of glutamate uptake mediates the neuroprotection exerted by activating group II or III metabotropic glutamate receptors on astrocytes

被引:96
作者
Yao, HH [1 ]
Ding, JH [1 ]
Zhou, F [1 ]
Wang, F [1 ]
Hu, LF [1 ]
Sun, T [1 ]
Hu, G [1 ]
机构
[1] Nanjing Med Univ, Dept Pharmacol & Neurobiol, Nanjing 210029, Jiangsu Prov, Peoples R China
关键词
astrocytes; C6 glioma cells; glutamate uptake; metabotropic glutamate receptors; neuroprotection; Parkinson's disease;
D O I
10.1111/j.1471-4159.2004.02937.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We investigated whether the activation of astroglial group II and III metabotropic glutamate receptors (mGluRs) could exert neuroprotective effects and whether the neuroprotection was related to glutamate uptake. Our results showed that the activation of astroglial group II or III mGluRs exerted neuroprotection against 1-methyl-4-phenylpyridinium (MPP+) astroglial conditioned medium-induced neurotoxicity in midbrain neuron cultures. Furthermore, MPP+ decreased glutamate uptake of primary astrocytes and C6 glioma cells, which was recovered by activating group II or III mGluRs. Specific group II or III mGluRs antagonists completely abolished the neuroprotective effects and the enhancement of glutamate uptake of their respective agonists. Our results showed that the primary cultured rat astrocytes and C6 glioma cells expressed receptor proteins for group II mGluR2/3, group III mGluR4, mGluR6 and mGluR7. C6 glioma cells expressed mRNA for group II mGluR3, group III mGluR4, mGluR6, mGluR7 and mGluR8. In conclusion, we confirmed that the activation of astroglial mGluRs exerted neuroprotection, and demonstrated that the mechanism underlying this protective role was at least partially related to the enhancement of glutamate uptake.
引用
收藏
页码:948 / 961
页数:14
相关论文
共 61 条
  • [1] Characterization of metabotropic glutamate receptors in rat C6 glioma cells
    Albasanz, JL
    Ros, M
    Martin, M
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 326 (01) : 85 - 91
  • [2] Anderson CM, 2000, GLIA, V32, P1
  • [3] Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins
    Aronica, E
    Gorter, JA
    Ijlst-Keizers, H
    Rozemuller, AJ
    Yankaya, B
    Leenstra, S
    Troost, D
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 17 (10) : 2106 - 2118
  • [4] Besong G, 2002, J NEUROSCI, V22, P5403
  • [5] Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia
    Biber, K
    Laurie, DJ
    Berthele, A
    Sommer, B
    Tölle, TR
    Gebicke-Härter, PJ
    van Calker, D
    Boddeke, HWGM
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 72 (04) : 1671 - 1680
  • [6] Deep hypothermia and rewarming alters glutamate levels and glycogen content in cultured astrocytes
    Bissonnette, B
    Pellerin, L
    Ravussin, P
    Daven, VB
    Magistretti, PJ
    [J]. ANESTHESIOLOGY, 1999, 91 (06) : 1763 - 1769
  • [7] Nitric oxide neurotoxicity in neurodegenerative diseases
    Boje, KMK
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 763 - 776
  • [8] PROTECTIVE EFFECT OF THE METABOTROPIC GLUTAMATE-RECEPTOR AGONIST, DCG-IV, AGAINST EXCITOTOXIC NEURONAL DEATH
    BRUNO, V
    COPANI, A
    BATTAGLIA, G
    RAFFAELE, R
    SHINOZAKI, H
    NICOLETTI, F
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 256 (01) : 109 - 112
  • [9] Bruno V, 1998, J NEUROSCI, V18, P9594
  • [10] THE INHIBITORY MGLUR AGONIST, S-4-CARBOXY-3-HYDROXY-PHENYLGLYCINE SELECTIVELY ATTENUATES NMDA NEUROTOXICITY AND OXYGEN GLUCOSE DEPRIVATION-INDUCED NEURONAL DEATH
    BUISSON, A
    CHOI, DW
    [J]. NEUROPHARMACOLOGY, 1995, 34 (08) : 1081 - 1087